Gene therapy approval advances for Duchenne MD | Psychotherapy for depression in pregnancy | Child neglect links to poor health later | Protection against eye injury
Release Date:
The U.S. Food and Drug Administration (FDA) have voted that when they meet formally at the end of May, approval goes forward for a treatment for Duchenne muscular dystrophy—a disabling genetic disease.Post partum depression is a significant issue for both women and their babies, and it doesn't come out of the blue—depression can occur before or during pregnancy.Child neglect leads to both later poor physical health—with things like inflammation—and mental health, such as depression.Would you wear protective eyewear to play tennis, badminton or Aussie Rules?
Gene therapy approval advances for Duchenne MD | Psychotherapy for depression in pregnancy | Child neglect links to poor health later | Protection against eye injury